Funding for this research was provided by:
Chang Gung Medical Foundation (CMRPVVL0111, CGRPG2F0011, CLRPG2C0021, CLRPG2C0022, CLRPG2C0023, CLRPG2C0024, CLRPG2G0081, CLRPG2G0082, CLRPG2G0083, CLRPG2L0021, CFRPG2L0021)
Received: 12 March 2023
Accepted: 8 May 2023
First Online: 26 May 2023
: The Institutional Review Board of CGMH approved the study protocol (IRB No. 202201186B0) and waived the requirement for informed consent. Patient information was deidentified and anonymized before analyses were conducted. This study was conducted in accordance with the tenets of the Declaration of Helsinki and the ethical regulations of the Institutional Review Board.
: The authors declare that this study was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interests.